Ádám, Ildikó and Kaló, Zoltán (2021) Development of public financing initiatives in pharmaceutical R&D – is it the key to the future of medicine? = A gyógyszeripari kutatás-fejlesztés állami finanszírozási kezdeményezéseinek fejlesztése - ez az orvostudomány jövőjének kulcsa? Kaleidoscope history, 11 (22). pp. 316-324. ISSN 20622597
|
Text
a_gyogyszeripari_kutatas.pdf Download (1MB) | Preview |
Abstract
The pharmaceutical research and development process only begin if the drug holds the promise of being profitable. In the past pharmaceutical companies aimed to find solutions for common diseases with high prevalence. Meanwhile, the unmet medical need did not decrease in several therapeutic areas. Public policy makers had to encourage pharmaceutical companies to invest in research and development in areas with high unmet medical need. Several public measures (including financing initiatives) were introduced. In this paper, we focus on the public research and development and regulatory incentives to accelerate investment. In the past decades, there has been a considerable increase in public funding in the European Union, which diverted the attention of innovators to areas with public priorities. Still, there are areas where public funding alone could not lead to a prompt solution.
Item Type: | Article |
---|---|
Subjects: | R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában R Medicine / orvostudomány > RS Pharmacy and materia medica / gyógyszerészet, gyógyászati eszközök |
Depositing User: | Zsolt Baráth |
Date Deposited: | 04 Oct 2021 08:17 |
Last Modified: | 04 Oct 2021 08:17 |
URI: | http://real.mtak.hu/id/eprint/131843 |
Actions (login required)
![]() |
Edit Item |